Literature DB >> 1628225

Preliminary evidence that incorporation of 5-fluorouracil into RNA correlates with antitumor response.

H Matsuoka1, H Ueo, K Sugimachi, T Akiyoshi.   

Abstract

A comparative study of two different species of a fluorouracil assay was conducted on 11 patients who had carcinoma that was deemed unresectable after the surgical operation. For these patients FU at a dose of 10 mg/kg was intravenously administered before operation, and portions of the tumors were resected within 120-150 min to assay both the (FU)RNA/RNA and FU/protein. After surgery, all patients were given FU alone either intravenously or orally. The FU, which was in an acid-soluble material (FU/protein), was not related to the antitumor effect of FU. However, the FU in RNA [(FU)RNA/RNA)] was found to be related to the antitumor effect of FU. When the concentration of (FU)RNA/RNA was above approximately 200 ng/mg, FU was effectual in unresectable carcinomas. It is probable that the (FU)RNA/RNA may be more suitable than FU/protein for predicting the antitumor effect of FU.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1628225     DOI: 10.3109/07357909209032750

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  5 in total

1.  Capecitabine in the management of colorectal cancer.

Authors:  Bradford R Hirsch; S Yousuf Zafar
Journal:  Cancer Manag Res       Date:  2011-03-24       Impact factor: 3.989

2.  5-FU toxicity and nutritional deficiencies.

Authors:  U Stenram
Journal:  Br J Cancer       Date:  1993-05       Impact factor: 7.640

3.  UCN-01 (7-hydroxystaurosporine) enhances 5-fluorouracil cytotoxicity through down-regulation of thymidylate synthetase messenger RNA.

Authors:  S Abe; T Kubota; Y Otani; T Furukawa; M Watanabe; K Kumai; M Kitajima
Journal:  Jpn J Cancer Res       Date:  2000-11

4.  Regulation of dihydropyrimidine dehydrogenase and pyrimidine nucleoside phosphorylase activities by growth factors and subsequent effects on 5-fluorouracil sensitivity in tumor cells.

Authors:  M Ueda; K Kitaura; O Kusada; Y Mochizuki; N Yamada; Y Terai; K Kumagai; K Ueki; M Ueki
Journal:  Jpn J Cancer Res       Date:  2000-11

5.  Clinical management of localized colon cancer with capecitabine.

Authors:  J Quidde; D Arnold; A Stein
Journal:  Clin Med Insights Oncol       Date:  2012-11-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.